Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 2 Tumor-Agnostic 1 Sarcoma 1 Gastrointestinal 1

Conditions

Interventions

Paclitaxel 26 Carboplatin 25 pembrolizumab 22 Gemcitabine 22 Nivolumab 20 Cisplatin 15 Bevacizumab 14 Docetaxel 13 Pemetrexed 12 Ipilimumab 12 Erlotinib Hydrochloride 12 Capecitabine 12 Fluorouracil 11 Irinotecan 10 Afatinib 10 eribulin 9 BI 6727 9 130-nm albumin-bound paclitaxel 9 Radiotherapy 8 Magnetic Resonance Spectroscopy 8 Leucovorin 8 Everolimus 8 Cyclophosphamide 8 Albumin-Bound Paclitaxel 8 olaparib 7 Oxaliplatin 7 lenvatinib 6 avelumab 6 Trastuzumab 6 Cetuximab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × ferric carboxymaltose × Tumor-Agnostic × Clear all

NCT02453334 2021-05-11

IRON CLAD

American Regent, Inc.

Phase 3 Completed

244 enrolled 33 charts

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡